LONG-TERM TREATMENT OF CEREBROTENDINOUS XANTHOMATOSIS WITH CHENODEOXYCHOLIC ACID
LONG-TERM TREATMENT OF CEREBROTENDINOUS XANTHOMATOSIS WITH CHENODEOXYCHOLIC ACID
复制标题
DOI:
10.1056/nejm198412273112601
复制
发表时间:
1984-01-01
影响因子:
158.5
通讯作者:
SHEFER, S
中科院分区:
文献类型:
--
作者:
BERGINER, VM;SALEN, G;SHEFER, S
The effect of chenodeoxycholic acid was studied in 17 patients with cerebrotendinous xanthomatosis. Before treatment, all subjects were symptomatic, with Achilles tendon xanthomas (in 15 of 17), cataracts (in 12 of 17), dementia (in 13 of 17), pyramidal-tract signs (in all 17), cerebellar dysfunction (in 13 of 17), mild peripheral neuropathy (in 7 of 17), EEG abnormalities (in 10 of 13) and abnormal cerebral computerized axial tomographic scans (in 10 of 12). After at least 1 yr of chenodeoxycholic acid treatment (750 mg/day), dementia cleared in 10 subjects and pyramidal and cerebellar signs disappeared in 5 and improved in another 8. Peripheral neuropathy was no longer detected in 6. The EEG became normal in 5 and showed fewer abnormalities in another 3 subjects. Cerebral computerized axial tomographic scans improved in 7 patients; the changes included the disappearance of a cerebellar xanthoma in 1 case. Concomitantly mean plasma cholestanol levels declined 3-fold and abnormal bile acid synthesis was suppressed. Long-term therapy with chenodeoxycholic acid may correct the biochemical abnormalities and arrest and possibly reverse the progression of cerebrotendinuous xanthomatosis.